{"id":"CHEMBL1076211","canonicalSmiles":"Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1","inchiKey":"FSKFPVLPFLJRQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLPERISONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mydeton","N-553 FREE BASE","N-553 [AS HYDROCHLORIDE]","NSC-107321","Tolperisone","Tolperisone hydrochloride"],"crossReferences":{"Wikipedia":["Tolperisone"],"drugbank":["DB06264"]},"childChemblIds":["CHEMBL1395150","CHEMBL2107740"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL115357","canonicalSmiles":"CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)NNC(=O)NNC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1","inchiKey":"HGDUWJVGIGLVOH-ZEQRLZLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL115357","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03891"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1190476","canonicalSmiles":"C[N+](C)(C)c1ccc(CNC(=O)c2cc3cc(OCc4ccccc4)ccc3n2Cc2cccc(C(=N)N)c2)cc1","inchiKey":"UFKJQTGPBFWMGT-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1190476","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02269"]},"childChemblIds":["CHEMBL540898"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198138","canonicalSmiles":"N=C(N)c1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CCC2CCCCC2)cc1","inchiKey":"DOTBZTLJSXFKCP-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198138","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07131"]},"childChemblIds":["CHEMBL596999"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198855","canonicalSmiles":"CC(C)(CC1Cc2ccccc2C1)NC[C@@H](O)COc1cc(CCC(=O)O)cc(F)c1F","inchiKey":"FQJISUPNMFRIFZ-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RONACALERET","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ronacaleret","Sb-751689"],"crossReferences":{"drugbank":["DB05255"]},"childChemblIds":["CHEMBL1083998"],"linkedTargets":{"rows":["ENSG00000036828"],"count":1},"linkedDiseases":{"rows":["EFO_0003931","EFO_0003882"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1200","canonicalSmiles":"CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N","inchiKey":"CMHHMUWAYWTMGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENOXINATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benoxinate","Conjucain","Dorsacain","Monofree oxybuprocaine","Oxybucaine","Oxybuprocaine"],"crossReferences":{"DailyMed":["benoxinate%20hydrochloride"],"PubChem":["11112575","56320722"],"Wikipedia":["Oxybuprocaine"],"drugbank":["DB00892"],"chEBI":["309594"]},"childChemblIds":["CHEMBL1200654"],"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["HP_0000989"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for pruritus."}
{"id":"CHEMBL1200343","canonicalSmiles":"CC(C)(C)N.CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC","inchiKey":"IYNMDWMQHSMDDE-MHXJNQAMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERINDOPRIL ERBUMINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1581","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aceon","Coversyl","Perindopril erbumine"],"synonyms":["MCN-A-2833-109","NSC-758929","Perindopril erbumine","Perindopril tert-butylamine","S-9490-3"],"crossReferences":{"DailyMed":["perindopril%20erbumine"],"chEBI":["8025"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["MONDO_0001134","EFO_0001645","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for coronary artery disease and hypertension and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201002","canonicalSmiles":"CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2.Cl","inchiKey":"FYBXRCFPOTXTJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARTEOLOL HYDROCHLORIDE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL839","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carteolol hydrochloride","Cartrol","Ocupress","Teoptic"],"synonyms":["ABBOTT-43326","Carteolol hcl","Carteolol hydrochloride","NSC-300906","OPC-1085"],"crossReferences":{"DailyMed":["carteolol%20hydrochloride"],"PubChem":["144204205","170465122","56463040"],"chEBI":["3438"]},"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591","ENSG00000188778"],"count":3},"linkedDiseases":{"rows":["EFO_0004190"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988 and is indicated for open-angle glaucoma."}
{"id":"CHEMBL1201162","canonicalSmiles":"CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21.Cl","inchiKey":"OSRUSFPMRGDLAG-QMGYSKNISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORZOLAMIDE HYDROCHLORIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL218490","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cosopt Pf","Dorzolamide hydrochloride","Trusopt"],"synonyms":["Dorzolamide (as hydrochloride)","Dorzolamide hcl","Dorzolamide hydrochloride","MK-507"],"crossReferences":{"DailyMed":["dorzolamide%20hydrochloride"],"PubChem":["170465119","56463558"],"chEBI":["4703"]},"linkedTargets":{"rows":["ENSG00000104267"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_0000516"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 3 approved indications."}
{"id":"CHEMBL1201202","canonicalSmiles":"CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)O)[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)O)[C@H]3NS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)[C@H](O)[C@H]1NS(=O)(=O)O","inchiKey":"KANJSNBRCNMZMV-ABRZTLGGSA-N","drugType":"Oligosaccharide","blackBoxWarning":true,"name":"FONDAPARINUX","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fondaparinux"],"crossReferences":{"DailyMed":["fondaparinux%20sodium"],"Wikipedia":["Fondaparinux"],"drugbank":["DB00569"],"chEBI":["61033"]},"childChemblIds":["CHEMBL1200644"],"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0009686","EFO_0001074","EFO_0001075","EFO_0000275","EFO_0004286","HP_0001873","HP_0001907","HP_0000083","MONDO_0100096","EFO_0003827","EFO_0003907","HP_0004419","EFO_0007541","EFO_0005672","HP_0004936"],"count":16},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201261","canonicalSmiles":"CCCC(=O)Nc1c(I)cc(I)c(CC(CC)C(=O)O)c1I","inchiKey":"YMOXVLQZFAUUKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TYROPANOIC ACID","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tyropanic acid","Tyropanoate","Tyropanoic Acid","Tyropanoic acid"],"crossReferences":{"Wikipedia":["Tyropanoic_acid"],"drugbank":["DB09340"]},"childChemblIds":["CHEMBL1200899"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969."}
{"id":"CHEMBL1201286","canonicalSmiles":"CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1","inchiKey":"GFRUPHOKLBPHTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENONIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxyphenonium","Oxyphenonium cation","Oxyphenonium ion"],"crossReferences":{"drugbank":["DB00219"]},"childChemblIds":["CHEMBL1200906"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201821","drugType":"Protein","blackBoxWarning":false,"name":"PALIFERMIN","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kepivance"],"synonyms":["Palifermin"],"crossReferences":{"DailyMed":["palifermin"],"DrugCentral":["4804"],"Wikipedia":["Palifermin"]},"linkedTargets":{"rows":["ENSG00000066468"],"count":1},"linkedDiseases":{"rows":["MONDO_0021063","EFO_0005952","EFO_0005555","EFO_1000690","EFO_0000565","MONDO_0015760","EFO_1001898","EFO_0000183","EFO_0000707","EFO_0004276","EFO_1001904","EFO_0000198","MONDO_0013730","EFO_0006859","EFO_0000222","MONDO_0044881","EFO_0004599","EFO_0000311","MONDO_0005301","EFO_0009688","EFO_0006475","Orphanet_79364","EFO_0000764","MONDO_0021193","EFO_0000574","MONDO_0004979","EFO_0001378","EFO_1001451"],"count":28},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 approved and 24 investigational indications."}
{"id":"CHEMBL1201864","canonicalSmiles":"C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N","inchiKey":"AZFLJNIPTRTECV-FUMNGEBKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIENOGEST","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Endometrion"],"synonyms":["Dienogest","M 18575","M-18575","MJR-35","STS 557","STS-557","ZK 37659","ZK-37659"],"crossReferences":{"DailyMed":["dienogest"],"Wikipedia":["Dienogest"],"drugbank":["DB09123"],"chEBI":["70708"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for menorrhagia and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229789","canonicalSmiles":"O=C(O)c1ccc2nc(-c3c(Cl)cccc3Cl)oc2c1","inchiKey":"XVNRKPCHMYOPPL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229789","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06907"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230607","canonicalSmiles":"CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C","inchiKey":"HUXYBQXJVXOMKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHA-793887","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PHA-793887","Pha-793887"],"crossReferences":{"PubChem":["137276012"],"drugbank":["DB12686"]},"linkedTargets":{"rows":["ENSG00000250506","ENSG00000156345","ENSG00000164885","ENSG00000134058","ENSG00000123374","ENSG00000135446","ENSG00000155111","ENSG00000105810","ENSG00000136807","ENSG00000059758","ENSG00000167258","ENSG00000138395","ENSG00000058091","ENSG00000117266","ENSG00000132964","ENSG00000248333","ENSG00000065883","ENSG00000102225","ENSG00000170312","ENSG00000185324"],"count":20},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1231806","canonicalSmiles":"Nc1nc2cc3[nH]c(NCCN4CCOCC4)nc3cc2c(=O)[nH]1","inchiKey":"JUHXOBNFTFUPKQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231806","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07564"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233058","canonicalSmiles":"OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O","inchiKey":"WQZGKKKJIJFFOK-PHYPRBDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALACTOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Galactose"],"crossReferences":{"PubChem":["29215384"],"chEBI":["28061"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1234162","canonicalSmiles":"COCCOCCOC","inchiKey":"SBZXBUIDTXKZTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234162","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209538","144210397"],"drugbank":["DB02935"],"chEBI":["46784"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236484","canonicalSmiles":"O=C(O)c1cscn1","inchiKey":"HMVYYTRDXNKRBQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236484","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03422"]},"childChemblIds":["CHEMBL4126899","CHEMBL1601420"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237023","drugType":"Antibody","blackBoxWarning":false,"name":"DENOSUMAB","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prolia","Prolia, Ranmark Xgeva","Prolia, xgeva","Xgeva"],"synonyms":["AMG 162","AMG-162","Denosumab","Denosumab biosimilar (ql-1206)","Denosumab biosimilar tk-006","QL-1206","QL1206","Ql1206","TK-006","TK006"],"crossReferences":{"DailyMed":["denosumab"],"DrugCentral":["4965"],"Wikipedia":["Denosumab"]},"linkedTargets":{"rows":["ENSG00000120659"],"count":1},"linkedDiseases":{"rows":["EFO_0004248","EFO_0003086","EFO_0003869","EFO_0000637","EFO_0003820","EFO_0001075","HP_0004349","EFO_0000756","EFO_0004274","EFO_0000681","MONDO_0007254","MONDO_0005271","EFO_0000266","EFO_0003882","EFO_0000305","EFO_1000984","EFO_1001951","HP_0000938","EFO_1000318","EFO_0003931","EFO_0000389","MONDO_0008903","EFO_1000786","EFO_1000789","EFO_0000400","EFO_0004215","EFO_0009870","HP_0003072","EFO_0000616","EFO_0000685","EFO_0000313","EFO_0004260","Orphanet_666","EFO_0000384","MONDO_0008315","EFO_0003060","MONDO_0002171","EFO_0009708","EFO_0008519","EFO_0003854","EFO_0001378","MONDO_0024880","EFO_0007176"],"count":43},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 9 approved and 29 investigational indications."}
{"id":"CHEMBL1237119","canonicalSmiles":"CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O","inchiKey":"PAJMKGZZBBTTOY-ZFORQUDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREPROSTINIL","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Remodulin","Tyvaso"],"synonyms":["15-AU-81","15AU81","L-606","LRX -15","LRX-15","Rumodolin","Treprostinil","Tresprostinil","UT-15","Uniprost"],"crossReferences":{"DailyMed":["treprostinil","treprostinil%20diolamine"],"drugbank":["DB00374"],"chEBI":["50861"]},"childChemblIds":["CHEMBL2107815"],"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0001361","MONDO_0100130","EFO_1001103","EFO_0002687","EFO_0003875","EFO_0000768","EFO_0005207","EFO_0000556","MONDO_0001999","EFO_0003843","EFO_1001145","EFO_1001459","MONDO_0005147","EFO_0000341","HP_0004419","EFO_0000717"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 3 approved and 14 investigational indications."}
{"id":"CHEMBL1240977","canonicalSmiles":"CN1CCCN=C1/C=C/c1cccc(O)c1","inchiKey":"VRYKTHBAWRESFI-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXANTEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxantel"],"crossReferences":{"drugbank":["DB13670"]},"childChemblIds":["CHEMBL4303678"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1241951","canonicalSmiles":"COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1","inchiKey":"FWYSMLBETOMXAG-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETERMOVIR","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prevymis"],"synonyms":["AIC 246","AIC-246","AIC246","Letermovir","MK-8228"],"crossReferences":{"DailyMed":["letermovir"],"drugbank":["DB12070"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications."}
{"id":"CHEMBL126432","canonicalSmiles":"CCCSc1cc(OC)c(CCN)cc1OC","inchiKey":"OLEVEPDJOFPJTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL126432","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["2C-T-7"],"drugbank":["DB01458"]},"childChemblIds":["CHEMBL2359200"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1276127","canonicalSmiles":"O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O","inchiKey":"CRDNMYFJWFXOCH-YPKPFQOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIRUBIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C.I. 75790","Couroupitine b","Indirubin","NSC-105327"],"crossReferences":{"PubChem":["26756711","26756712","26756713"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1323699","canonicalSmiles":"CCCCC(CC)COC(=O)c1ccc(N(C)C)cc1","inchiKey":"WYWZRNAHINYAEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PADIMATE O","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arlatone uvb","Escalol 507","Spectraban 25","Spectraban 4","Spectraban ultra"],"synonyms":["Ethylhexyl dimethyl paba","Eusolex 6007","Octyl dimethyl paba","Padimate o","Padimate-o","Pamimate o","Uvasorb dmo"],"crossReferences":{"PubChem":["144204564","144209619","144213879","170465499","17389329","26752790","49735490"],"drugbank":["DB11570"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for freckles."}
{"id":"CHEMBL13291","canonicalSmiles":"CN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21","inchiKey":"ROYOYTLGDLIGBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDIAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Erispan","Fludiazepam"],"crossReferences":{"Wikipedia":["Fludiazepam"],"drugbank":["DB01567"],"chEBI":["31618"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1334033","canonicalSmiles":"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1.O=C(O)/C=C\\C(=O)O","inchiKey":"JDZOTSLZMQDFLG-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERHEXILINE MALEATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL75880","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"," United Kingdom"],"classes":["Hepatotoxicity"," Neurotoxicity"],"year":1985},"tradeNames":["Pexid","Pexsig"],"synonyms":["NSC-758409","Perhexiline maleate","Perhexilinum"],"crossReferences":{"PubChem":["144204948","170466435","26748746","56422147","855892"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974. It was withdrawn in Spain and  United Kingdom initially in 1985 due to Hepatotoxicity and  Neurotoxicity."}
{"id":"CHEMBL1353","canonicalSmiles":"O=C([O-])O.[Na+]","inchiKey":"UIIMBOGNXHQVGW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM BICARBONATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baking Soda","Monosodium Carbonate","Neut","Nurse harveys","S-bicarb","S-bicarb sf","Soda Mint","Sodibic","Sodium bicarbonate","Thamicarb"],"synonyms":["B1654","Baking soda","Bicarbonate of soda","Carbonic acid monosodium salt","Carbonic acid sodium salt (1:1)","E-500(II)","E500","Genitron tp-bch 51051","Hydrocerol esc 5671","INS NO.500(II)","INS-500(II)","NSC-134031","Nabic","Natrii hydrogenocarbonas","Natrum bicarbonicum","Sodium Bicarbonate","Sodium acid carbonate","Sodium bicarbonate","Sodium bicarbonate anhydrous"],"crossReferences":{"DailyMed":["sodium%20bicarbonate"],"DrugCentral":["4205"],"Wikipedia":["Sodium_bicarbonate"],"drugbank":["DB01390"],"chEBI":["32139"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for gastroesophageal reflux disease and pain and has 25 investigational indications."}
{"id":"CHEMBL1369407","canonicalSmiles":"CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1","inchiKey":"WDQPAMHFFCXSNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1369407","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174006615","49681815","855829"],"drugbank":["DB00845"],"chEBI":["3749"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1409","canonicalSmiles":"COCCCC/C(=N\\OCCN)c1ccc(C(F)(F)F)cc1.O=C(O)/C=C\\C(=O)O","inchiKey":"LFMYNZPAVPMEGP-PIDGMYBPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUVOXAMINE MALEATE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL814","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Faverin 100","Faverin 50","Floxyfral","Fluvoxamine maleate","Luvox","Luvox cr"],"synonyms":["DU-23000","DU23000","Faverin","Fevarin","Fluvoxamine hydrogenmaleate","Fluvoxamine maleate","NSC-759602"],"crossReferences":{"DailyMed":["fluvoxamine%20maleate"],"PubChem":["50106274","50106275","93576625"]},"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_0000694","EFO_0004262","MONDO_0100096","MONDO_0002009","EFO_0004242"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for obsessive-compulsive disorder and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1439","canonicalSmiles":"C[C@]1(Cn2ccnn2)[C@H](C(=O)[O-])N2C(=O)C[C@H]2S1(=O)=O.[Na+]","inchiKey":"RFMIKMMOLPNEDG-QVUDESDKSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TAZOBACTAM SODIUM","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL404","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tazocillin"],"synonyms":["CL 307,579","CL-307579","Tazobactam (as sodium)","Tazobactam sodium","Tazobactam sodium salt","Tazobactum sodium"],"crossReferences":{"DailyMed":["tazobactam%20sodium"],"PubChem":["144205137","170465148"],"chEBI":["85192"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 9 approved and 1 investigational indication."}
{"id":"CHEMBL1476022","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"IIVBFTNIGYRNQY-YQLZSBIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOMEGESTROL ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nomegestrol acetate","ORG 10486-0","ORG-10486-0","TX 066","TX-066","Zoely"],"crossReferences":{"PubChem":["56463139"],"drugbank":["DB13981"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL149752","canonicalSmiles":"CCCCCCCc1ccc(O)cc1","inchiKey":"KNDDEFBFJLKPFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Heptyl-Phenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Heptyl-Phenol","4-Heptylphenol"],"crossReferences":{"PubChem":["144211865"],"drugbank":["DB03941"],"chEBI":["34438"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL151445","canonicalSmiles":"OCC(O)CN1CCN(c2ccccc2)CC1","inchiKey":"PTVWPYVOOKLBCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROPROPIZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Catabex","Dipropizine","Ditustat","Dopropizin","Dropropizine","Katril","Larylin","NSC-757820","Ribex","Tussilex","U.C.B.-1967","UCB 1967","UCB-1967"],"crossReferences":{"PubChem":["104171374","144204393","170466654","56422462"],"Wikipedia":["Dropropizine"],"drugbank":["DB13785"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1552","canonicalSmiles":"C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O","inchiKey":"GHCZAUBVMUEKKP-GYPHWSFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOCHENODEOXYCHOLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glycochenodeoxycholate"],"crossReferences":{"drugbank":["DB02123"],"chEBI":["36274"]},"childChemblIds":["CHEMBL2028607"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1628227","canonicalSmiles":"CN(C)CCC=C1c2ccccc2COc2ccccc21","inchiKey":"ODQWQRRAPPTVAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOXEPIN","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sinepin","Sinequan"],"synonyms":["Doxepin","P-3693A","Zonalon"],"crossReferences":{"DailyMed":["doxepin%20hydrochloride"],"PubChem":["174006603"],"TG-GATEs":["39"],"drugbank":["DB01142"],"chEBI":["4710"]},"childChemblIds":["CHEMBL1628234"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","HP_0000989","EFO_0000555","HP_0000726","MONDO_0007254","EFO_0000274","EFO_0003843","EFO_0004698","EFO_0005531","EFO_0000289","MONDO_0002050","EFO_0003761","MONDO_0007079","EFO_0005230","EFO_1001904"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and has 7 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL16370","canonicalSmiles":"ClCCCl","inchiKey":"WSLDOOZREJYCGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,2-DICHLOROETHANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2-Dichloro-Ethane","1,2-Dichloroethane","Dichloroethylene"],"crossReferences":{"PubChem":["144209664","17389930"],"Wikipedia":["1,2-Dichloroethane"],"drugbank":["DB03733"],"chEBI":["27789"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697744","canonicalSmiles":"O=C(O)CSCC(=O)NC1CCSC1=O","inchiKey":"QGFORSXNKQLDNO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERDOSTEINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Erdosteine","Mucotec"],"crossReferences":{"PubChem":["124896662","144206727","170465586"],"drugbank":["DB05057"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1705525","canonicalSmiles":"CC(CNC(=O)c1cccnc1)NC(=O)c1cccnc1","inchiKey":"KTXBOOWDLPUROC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICARAVEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antevas","Nicaraven"],"crossReferences":{"PubChem":["144205407","29216176"],"drugbank":["DB06397"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL171679","canonicalSmiles":"COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O","inchiKey":"IAOZJIPTCAWIRG-QWRGUYRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPARTAME","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APM","Aspartame","Aspartame (e951)","E-951","E951","Ins no.951","Ins-951","Methyl aspartylphenylalanate","NSC-758953","Nutrasweet","Pal sweet","SC-18862","Sladex","Zero-cal"],"crossReferences":{"PubChem":["144204631","144205012","144213282","170466109","17390037","26752906","47193879"],"Wikipedia":["Aspartame"],"drugbank":["DB00168"],"chEBI":["2877"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1740513","canonicalSmiles":"CC(C)Nc1ncccn1","inchiKey":"FTCYIGBVOHNHCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISAXONINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1984},"tradeNames":[],"synonyms":["Isaxonine","NSC-760406"],"childChemblIds":["CHEMBL1697751"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1984 due to Hepatotoxicity."}
{"id":"CHEMBL1741078","canonicalSmiles":"CC1CCC(C(=O)N(c2cc(-c3ccccc3)sc2C(=O)O)C2CCC(O)CC2)CC1","inchiKey":"CKVYPTIWERNFSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VCH-759","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL1673159"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743757","canonicalSmiles":"CC(C)[C@H](N)C(=O)O[C@@H]1[C@@H](CO)O[C@@H](n2ccc(N)nc2=O)[C@]1(C)O.Cl.Cl","inchiKey":"XENHXZMAOSTXGD-DSMKLBDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALOPICITABINE DIHYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL393820","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NM-283 DIHYDROCHLORIDE","NM283","Valopicitabine dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1744033","drugType":"Small molecule","blackBoxWarning":false,"name":"BISMUTH SUBCITRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bismuth Subcitrate","Colloidal bismuth subcitrate","Tripotassium dicitratobismuthate"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL176467","canonicalSmiles":"CC1(c2ccc(Oc3ccccc3)cc2)C(=O)NC(=O)NC1=O","inchiKey":"RTBMLCLTYAPKIF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL176467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03368"],"chEBI":["43179"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL176602","canonicalSmiles":"CC(C)C[C@H](C(=O)NO)N(Cc1ccccc1)[P@](C)(=O)c1ccccc1","inchiKey":"KGUVBHLPMGERAT-NIYFSFCBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL176602","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08507"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1774645","canonicalSmiles":"CNc1ccc(-c2nc3ccc([18F])cc3s2)cc1","inchiKey":"QLWFXLJVGCECSV-HUYCHCPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1774645","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1774642","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15457"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1795071","canonicalSmiles":"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O","inchiKey":"JFMWPOCYMYGEDM-XFULWGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUXOLITINIB PHOSPHATE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1789941","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jakafi"],"synonyms":["INCB-018424 PHOSPHATE","INCB-018424 SALT","INCB-18424 PHOSPHATE","INCB018424 PHOSPHATE","INCB018424 SALT","Ruxolitinib (as phosphate)","Ruxolitinib monophosphate","Ruxolitinib phosphate"],"crossReferences":{"DailyMed":["ruxolitinib%20phosphate"],"chEBI":["66917"]},"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434"],"count":2},"linkedDiseases":{"rows":["EFO_1000253","EFO_1001958","EFO_0000220","EFO_0000466","EFO_0000222","EFO_0000274","EFO_0002429","EFO_0000305","HP_0011974","EFO_0002430","EFO_0000339","EFO_0004192","EFO_0001068","EFO_0000095","EFO_0000676","MONDO_0024880","EFO_1000042","EFO_1000494"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 3 approved and 10 investigational indications."}
{"id":"CHEMBL1908359","canonicalSmiles":"O=P([O-])([O-])F.[Na+].[Na+]","inchiKey":"BFDWBSRJQZPEEB-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM MONOFLUOROPHOSPHATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Extra-strength aim","Mono-tridin"],"synonyms":["NSC-248","Sodium fluorophosphate","Sodium monofluorophosphate"],"crossReferences":{"DrugCentral":["4252"],"drugbank":["DB09484"],"chEBI":["86431"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL1915540","canonicalSmiles":"CN[C@@H]1CCN(c2cc(NCC3CC3)nc(N)n2)C1","inchiKey":"ISBHYKVAFKTATD-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADRIFORANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adriforant","NVP-ZPL389-NX","PF-03893787","PF-3893787","Pf-03893787","ZPL-389","ZPL-389-NX","ZPL-3893787","ZPL389-NX"],"crossReferences":{"drugbank":["DB15027"]},"linkedTargets":{"rows":["ENSG00000134489"],"count":1},"linkedDiseases":{"rows":["EFO_0000676","MONDO_0004979","EFO_0000274"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1921976","canonicalSmiles":"CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1","inchiKey":"OZPFIJIOIVJZMN-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORTERONEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Orteronel","TAK-700"],"crossReferences":{"Wikipedia":["Orteronel"],"drugbank":["DB12066"]},"linkedTargets":{"rows":["ENSG00000148795"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000673","MONDO_0007254","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2103860","canonicalSmiles":"COC(=O)[C@H](c1ccccc1)N1CCC(c2ccc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)cc2)CC1","inchiKey":"WSYALRNYQFNNGP-HKBQPEDESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"USISTAPIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-16269110","JNJ16269110","R-256918","R256918","Usistapide"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105435","canonicalSmiles":"CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCCOC(=O)C(C)(C)Oc1ccc(Cl)cc1","inchiKey":"JLRNKCZRCMIVKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMFIBRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CLY-503","Cholesolvin","Diclofibrate","Simfibrate"],"crossReferences":{"PubChem":["170466018"],"drugbank":["DB13433"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105883","canonicalSmiles":"C=COC=C","inchiKey":"QYKIQEUNHZKYBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINYL ETHER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vinyl ether"],"crossReferences":{"drugbank":["DB13690"],"chEBI":["81293"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106059","canonicalSmiles":"C=CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"AHMMSNQYOPMLSX-CNQKSJKFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOLDENONE UNDECYLENATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BA-29038","Boldenone","Boldenone 10-undecenoate","Boldenone undecenoate","Boldenone undecylenate","Dehydrotestosterone","Equipoise","NSC-79102","Parenabol","Vebonol"],"crossReferences":{"drugbank":["DB14639"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107888","drugType":"Antibody","blackBoxWarning":false,"name":"TALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C21/AL-90","HU-901","TNX-901","Talizumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108293","drugType":"Gene","blackBoxWarning":false,"name":"RIFERMINOGENE PECAPLASMID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nv1fgf","Riferminogene pecaplasmid","XRP-0038","XRP0038"],"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108375","drugType":"Enzyme","blackBoxWarning":false,"name":"DUTEPLASE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Duteplase"],"description":"Enzyme drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108427","drugType":"Protein","blackBoxWarning":false,"name":"MENOTROPINS","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Humegon","Menopur","Merional","Normegon","Pergonal","Pergonal low lh"],"synonyms":["FSH","Follicle stimulating hormone","Follotropin","HMG","Human follicle stimulating hormone","Menotrophin","Menotropins","Menotropins (fsh;lh)"],"crossReferences":{"DailyMed":["menotropins%20(fsh;lh)"]},"linkedTargets":{"rows":["ENSG00000170820","ENSG00000138039"],"count":2},"linkedDiseases":{"rows":["EFO_0004248","MONDO_0002146","MONDO_0002259","EFO_0000545","EFO_0000279","EFO_0008560","EFO_0000660","Orphanet_478","MONDO_0018555","EFO_0002950"],"count":10},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 8 investigational indications."}
{"id":"CHEMBL2108553","drugType":"Unknown","blackBoxWarning":false,"name":"PEPPERMINT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ae-peppermint","B1449","Brandy mint flowering top","Lamb mint flowering top","Mentha crispa flowering top","Mentha dumetorum flowering top","Mentha piperita","Mentha piperita flowering top","Mentha x piperita","Mentha x piperita flowering top","Peppermint","Peppermint flowering top","Peppermint powder","Peppermint whole","Peppermint, fresh","Peppermint,fresh"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108661","drugType":"Unknown","blackBoxWarning":false,"name":"VEHICLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vehicle"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109452","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-4212","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-4212","MEDI4212","Medi-4212"],"linkedTargets":{"rows":["ENSG00000211891"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0000274","MONDO_0004784"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109586","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-780","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-780","Amg 780","Amg-780"],"linkedTargets":{"rows":["ENSG00000091879","ENSG00000154188"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110652","canonicalSmiles":"CCn1c2c(c3ccccc31)CCSC2(C)CCN(C)C","inchiKey":"BRPOADLGOFPKKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANDAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tandamine"],"crossReferences":{"drugbank":["DB09192"]},"childChemblIds":["CHEMBL2104802"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2111107","canonicalSmiles":"O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)C2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O","inchiKey":"WHRODDIHRRDWEW-ZWYCLXBASA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"SUGAMMADEX","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Sugammadex"],"crossReferences":{"DailyMed":["sugammadex%20sodium"]},"childChemblIds":["CHEMBL2107374"],"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 9 investigational indications."}
{"id":"CHEMBL211471","canonicalSmiles":"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.COS(=O)(=O)[O-]","inchiKey":"OSZNNLWOYWAHSS-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NEOSTIGMINE METHYLSULFATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL278020","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bloxiverz","Neostigmine methylsulfate","Prostigmine","Robinul-neostig"],"synonyms":["Intrastigmina","NSC-93753","Neostigmine methyl sulfate","Neostigmine methylsulfate","Neostigmine methylsulphate","Neostigmine metilsulfate","Neostigmini metilsulfas","Syntostigmin"],"crossReferences":{"DailyMed":["neostigmine%20methylsulfate"],"PubChem":["56422780","855838"],"chEBI":["7516"]},"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0004991","HP_0003270","HP_0025267","HP_0002315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for myasthenia gravis and has 1 investigational indication."}
{"id":"CHEMBL22","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC","inchiKey":"IEDVJHCEMCRBQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOPRIM","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ipral","Ledatrim","Monotrim","Proloprim","Proloprin","Syraprim","Tiempe","Trimethoprim","Trimogal","Trimopan","Trimpex","Trimpex 200","Triprimix 200"],"synonyms":["BW 56-72","BW-56-72","Infectotrimet","NIH-204","NSC-106568","Polytrim","Primsol","TCMDC-125538","Trimethoprim","Trimethoprimum","Wellcoprim"],"crossReferences":{"DailyMed":["trimethoprim","trimethoprim%20hydrochloride","trimethoprim%20sulfate"],"PubChem":["104171255","11111923","11111924","11113621","124881732","144203842","144207355","170464633","17389524","174316130","26747124","26747125","26751820","50085866","50104512","50104513","85231275","85747719","857743","90340764"],"Wikipedia":["Trimethoprim"],"drugbank":["DB00440"],"chEBI":["45924"]},"childChemblIds":["CHEMBL2110367","CHEMBL2237501","CHEMBL1430611","CHEMBL2237502","CHEMBL1201080"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 5 approved and 26 investigational indications."}
{"id":"CHEMBL258734","canonicalSmiles":"CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C\\[C@@H]2C[C@@]2(C(=O)NS(=O)(=O)C2CC2)NC(=O)[C@@H]2C[C@@H](OC(=O)N3Cc4cccc(F)c4C3)CN2C1=O","inchiKey":"ZVTDLPBHTSMEJZ-JSZLBQEHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANOPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danoprevir","R-05190591","R05190591","RO-5190591","RO5190591"],"crossReferences":{"drugbank":["DB11779"]},"childChemblIds":["CHEMBL2146090"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL259126","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CC[C@H](O)CC4=CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"VVUQRXPUVKXAIO-XFUVECHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL259126","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01455"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259724","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"UJLXYODCHAELLY-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL259724","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03103"],"chEBI":["18075"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273101","canonicalSmiles":"Cc1c(Br)c(=O)oc2c(Br)c(O)ccc12","inchiKey":"MSOLROYRAHCJNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL273101","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24823436"],"drugbank":["DB07802"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL274826","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"AEMFNILZOJDQLW-QAGGRKNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROSTENEDIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Androstenedione"],"crossReferences":{"PubChem":["144204444","144209467","144210896","170465907","17389251","17389252","26751578","29215020","50104208","85148334","855972"],"Wikipedia":["Androstenedione"],"drugbank":["DB01536"],"chEBI":["16422"]},"childChemblIds":["CHEMBL2311155"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275742","canonicalSmiles":"CC(C)NC[C@@H](O)COc1cccc2ccccc12","inchiKey":"AQHHHDLHHXJYJD-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXPROPRANOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexpropranolol","Propranolol, (r)-"],"crossReferences":{"PubChem":["104171303","11111608","11111609","11112324","11112325","11112326","11113604","11113728","124881054","124882253","144203986","170464682","26751915"],"drugbank":["DB03322"],"chEBI":["8736"]},"childChemblIds":["CHEMBL1358662"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL283196","canonicalSmiles":"O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12","inchiKey":"VFMMPHCGEFXGIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHA-NAPHTHOFLAVONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7,8-Benzoflavone","Alpha-Naphthoflavone","Alpha-Naphtholflavone","Alpha-Naphtoflavone"],"crossReferences":{"PubChem":["11113127","124882822","26754187"],"Wikipedia":["Alpha-Naphthoflavone"],"drugbank":["DB07453"],"chEBI":["76995"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28333","canonicalSmiles":"CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21","inchiKey":"YLCXGBZIZBEVPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nobrium"],"synonyms":["Medazepam","Pamnace"],"crossReferences":{"PubChem":["144206658","26757942"],"Wikipedia":["Medazepam"],"drugbank":["DB13437"]},"childChemblIds":["CHEMBL2106842"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anxiety."}
{"id":"CHEMBL284348","canonicalSmiles":"Nc1ccncc1","inchiKey":"NUKYPUAOHBNCPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DALFAMPRIDINE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","Fampridine (4-aminopyridine)","NSC-15041"],"crossReferences":{"DailyMed":["dalfampridine"],"PubChem":["104171097","11110683","11113806","124879040","124879042","136964060","144203616","144207991","170466526","26747141","26751980","26751983","50104658","8139900","90341267"],"Wikipedia":["4-Aminopyridine"],"drugbank":["DB06637"],"chEBI":["34385"]},"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000168263","ENSG00000129159","ENSG00000053918","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000135519","ENSG00000158445","ENSG00000177301","ENSG00000089558","ENSG00000168418","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000171385","ENSG00000184611"],"count":40},"linkedDiseases":{"rows":["HP_0001257","EFO_0009602","EFO_0007405","HP_0002140","EFO_0003782","Orphanet_97","EFO_1000809","EFO_1001919","EFO_0003929","EFO_0004335","EFO_0009490","MONDO_0021553","HP_0000083","Orphanet_83419","MONDO_0005301","EFO_0008520","EFO_0000712","EFO_0007292","EFO_1000632","EFO_0003918","EFO_0008522"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for multiple sclerosis and has 15 investigational indications."}
{"id":"CHEMBL294144","canonicalSmiles":"COc1cccc2c1CCC(=O)N2CCCN1CCN(c2cccc(Cl)c2)CC1","inchiKey":"TZZGTNZBLPCBIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL294144","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05422"]},"childChemblIds":["CHEMBL2115473","CHEMBL2115061"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL30336","canonicalSmiles":"COc1cc(CC(C)N)cc(OC)c1OC","inchiKey":"WGTASENVNYJZBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL30336","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01516"]},"childChemblIds":["CHEMBL534688"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303960","canonicalSmiles":"COCc1cccc(C[C@H](O)/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCSCCCC(=O)OC)c1","inchiKey":"FBQUXLIJKPWCAO-AZIFJQEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVENPROST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-ono-4819","ONO-4819","Rivenprost"],"linkedTargets":{"rows":["ENSG00000171522"],"count":1},"linkedDiseases":{"rows":["EFO_0000729"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3137326","canonicalSmiles":"[2H]C([2H])([2H])Oc1cc2c(cc1OC([2H])([2H])[2H])C1CC(=O)C(CC(C)C)CN1CC2","inchiKey":"MKJIEFSOBYUXJB-LIJFRPJRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DUTETRABENAZINE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL117785","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Austedo"],"synonyms":["Deutetrabenazine","Dutetrabenazine","SD-809"],"crossReferences":{"DailyMed":["deutetrabenazine"]},"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","EFO_0004280","MONDO_0003441","EFO_0004895","EFO_1000632","EFO_0004152"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for chorea and huntington disease and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL31634","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br","inchiKey":"ODZBBRURCPAEIQ-PIXDULNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIVUDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BVDU","Brivudin","Brivudine","Bromovinyldeoxyuridine","NSC-633770","RP-101","RP101","Zostex"],"crossReferences":{"PubChem":["144204764","50105913"],"Wikipedia":["Brivudine"],"drugbank":["DB03312"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3187812","canonicalSmiles":"CC(=O)S[C@H](C(=O)N[C@H]1Cc2ccccc2[C@H]2CCC[C@@H](C(=O)O)N2C1=O)C(C)C","inchiKey":"FXKFFTMLFPWYFH-RDGPPVDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILEPATRIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVE-7688","AVE7688","Ave7688","Ilepatril"],"crossReferences":{"PubChem":["144210558"],"drugbank":["DB06604"]},"linkedTargets":{"rows":["ENSG00000196549","ENSG00000159640"],"count":2},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL319516","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(P(=O)(O)O)c(P(=O)(O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"WCMLXBUNHNAMNH-UIOOFZCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL319516","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02336"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3244648","canonicalSmiles":"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1.[Na+].[Na+]","inchiKey":"DASQOOZCTWOQPA-GXKRWWSZSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"METHOTREXATE SODIUM","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL34259","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abitrexate","Folex","Folex pfs","Methotrexate lpf","Methotrexate preservative free","Methotrexate sodium","Methotrexate sodium preservative free","Mexate","Mexate-aq","Mexate-aq preserved","Trexall","Xatmep"],"synonyms":["ADX-2191 SODIUM","Disodium methotrexate","Methotrexate (as disodium)","Methotrexate disodium","Methotrexate disodium salt","Methotrexate sodium","Methotrexate sodium salt","Methotrexate, sodium salt"],"crossReferences":{"DailyMed":["methotrexate%20sodium"],"chEBI":["50679"]},"linkedTargets":{"rows":["ENSG00000228716"],"count":1},"linkedDiseases":{"rows":["EFO_0000220"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL330572","canonicalSmiles":"N=C(N)c1ccc(O)c(CN2CC[C@H](NS(=O)(=O)c3cc4ncccc4s3)C2=O)c1","inchiKey":"PQJGWYQPOHCEDO-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL330572","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02744"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL335315","canonicalSmiles":"CC(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"IBONACLSSOLHFU-JAJWTYFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL335315","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02320"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544564","canonicalSmiles":"C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O","inchiKey":"QGKQXZFZOIQFBI-XSWYFRFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3544564","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01479"],"chEBI":["79878"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544945","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR-113945","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sar-113945"],"linkedTargets":{"rows":["ENSG00000104365"],"count":1},"linkedDiseases":{"rows":["MONDO_0005178"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545037","drugType":"Small molecule","blackBoxWarning":false,"name":"STX107","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Stx107"],"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["Orphanet_908"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545038","drugType":"Small molecule","blackBoxWarning":false,"name":"S-237648","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-237648"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545176","drugType":"Small molecule","blackBoxWarning":false,"name":"DB959","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Db959","T3D-959"],"linkedTargets":{"rows":["ENSG00000112033","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545201","drugType":"Small molecule","blackBoxWarning":false,"name":"TA-5493","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ta-5493"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545306","drugType":"Unknown","blackBoxWarning":true,"name":"SULFUR HEXAFLUORIDE LIPID MICROSPHERE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lumason"],"synonyms":["Sulfur hexafluoride lipid microsphere","Sulfur hexafluoride lipid-type a microspheres"],"crossReferences":{"DailyMed":["sulfur%20hexafluoride%20lipid-type%20a%20microspheres"]},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2014 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL36633","canonicalSmiles":"NC(=O)CN1CC(O)CC1=O","inchiKey":"IHLAQQPQKRMGSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXIRACETAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP 21690E","CGP-21690E","GNF-PF-1005","Oxiracetam"],"crossReferences":{"PubChem":["50106803","85231168","90341150"],"Wikipedia":["Oxiracetam"],"drugbank":["DB13601"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707208","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS GLYCINE SULFATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fe-cap","Ferrocontin continus","Kelferon","Plesmet"],"synonyms":["Ferrous glycine sulfate","Ferrous glycine sulphate","Iron(ii) glycine sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anemia (phenotype)."}
{"id":"CHEMBL3707367","canonicalSmiles":"OCCOc1ccc(Cl)cc1","inchiKey":"GEGSSUSEWOHAFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-(4-CHLORPHENOXY)-ETHANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-(p-chlorophenoxy)ethanol","2-(4-chlorphenoxy)-ethanol","2-(p-chlorophenoxy)ethanol","Chloro-p-phenoxetol","Chlorophetanol","Ethanol, 2-(p-chlorophenoxy)-","Fungisan","Mycotetracid","NSC-8133","P-chlorophenyl glycol ether","P-chlorophenyl monoglycol ether"],"crossReferences":{"drugbank":["DB11368"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707403","canonicalSmiles":"CCCCc1oc2ccc(C(=O)OC(C)C)cc2c1C(=O)c1ccc(CCCN(CCCC)CCCC)cc1","inchiKey":"ZCENNVQCOZQSGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CELIVARONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Celivarone","K45001587E","SSR149744C","Ssr149744","UNII-K45001587E"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL376756","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"RITKWYDZSSQNJI-INXYWQKQSA-N","drugType":"Protein","blackBoxWarning":false,"name":"KISSPEPTIN-10","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Human metastin 45-54","Kisspeptin-10","Kisspeptin-10 (human)"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3786182","canonicalSmiles":"O=C(O)c1ccc(CN2CCC(CN[C@@H]3C[C@H]3c3ccccc3)CC2)cc1","inchiKey":"LRULVYSBRWUVGR-FCHUYYIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2879552","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk2879552"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3813842","canonicalSmiles":"CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12","inchiKey":"LGWACEZVCMBSKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAXALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G-02441729","G02441729","GDC-0084","GDC0084","Paxalisib","Rg-7666"],"crossReferences":{"drugbank":["DB15186"]},"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["MONDO_0044887","MONDO_0007254","MONDO_0024880","EFO_0000519","EFO_1000158"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3894518","canonicalSmiles":"CCn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1","inchiKey":"ZGRDYKFVDCFJCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8835","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-8835","AZD8835","Azd 8835","Azd-8835","Azd8835"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3961037","canonicalSmiles":"CC(c1ccccc1)c1ccc(O)cc1O","inchiKey":"PQSXNIMHIHYFEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3961037","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14120"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989409","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](COP(=O)(O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)CC)C(C)C","inchiKey":"XTAUIEMSNCLHEG-GGVFYUGVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FORIGERIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lupuzor"],"synonyms":["Forigerimod","IPP 201101","IPP-201101","Rigerimod"],"childChemblIds":["CHEMBL3989801"],"linkedTargets":{"rows":["ENSG00000109971"],"count":1},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 1 investigational indication."}
{"id":"CHEMBL3989923","canonicalSmiles":"O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Mg+2]","inchiKey":"MPAZKXHCZWDZDY-FFNUKLMVSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PITAVASTATIN MAGNESIUM","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201753","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zypitamag"],"synonyms":["Pitavastatin magnesium"],"crossReferences":{"DailyMed":["pitavastatin%20magnesium"]},"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["MONDO_0021187","HP_0003119"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for hyperlipidemia and abnormal circulating lipid concentration."}
{"id":"CHEMBL405862","canonicalSmiles":"CO[C@@H]1C[C@@H](C[C@H]2CC[C@H](C)[C@H]([C@@H](C)C(=O)O)O2)O[C@]2(O[C@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@@](O)(CO)[C@H](C)C[C@@H]5C)C[C@@H]4C)O3)C[C@H]2C)[C@@H]1C","inchiKey":"DANUORFCFTYTSZ-SJSJOXFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIGERICIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nigericin"],"crossReferences":{"Wikipedia":["Nigericin"],"drugbank":["DB14056"],"chEBI":["7569"]},"childChemblIds":["CHEMBL2165715"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL406254","canonicalSmiles":"O=c1[nH]c(Nc2ccccc2)nc2c1ncn2CCCCO","inchiKey":"JHBXNPBKSPYOFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL406254","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02495"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL416146","canonicalSmiles":"Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1","inchiKey":"MNJVRJDLRVPLFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETORICOXIB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arcoxia"],"synonyms":["Etoricoxib","L-791456","MK-0663"],"crossReferences":{"PubChem":["144205759","170465621","26758000"],"Wikipedia":["Etoricoxib"],"drugbank":["DB01628"],"chEBI":["6339"]},"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005687","EFO_0003820","MONDO_0041052","EFO_0000756","EFO_0004274","EFO_0010072","EFO_0003898","Orphanet_3389","EFO_0003843","MONDO_0008315","EFO_0005755","HP_0002315","EFO_0000546","EFO_0009582","EFO_0000649","EFO_0000764","EFO_0004616","HP_0003419","HP_0100607","EFO_1002012","MONDO_0005178","EFO_1001434"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 14 investigational indications."}
{"id":"CHEMBL4227505","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1","inchiKey":"ADZBMFGQQWPHMJ-RHSMWYFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BLZ945","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Blz945"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL429","canonicalSmiles":"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1","inchiKey":"SGUAFYQXFOLMHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LABETALOL","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AH-5158A FREE BASE","Ibidomide","Labetalol","Normodyne","Normozide","SCH-15719W FREE BASE","Trandate"],"crossReferences":{"DailyMed":["labetalol%20hydrochloride"],"PubChem":["90341718"],"TG-GATEs":["40"],"Wikipedia":["Labetalol"],"drugbank":["DB00598"],"chEBI":["6343"]},"childChemblIds":["CHEMBL1200323"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0002610","HP_0002140","EFO_0007486","EFO_0005669","EFO_0003768","EFO_0000319","EFO_0003843","EFO_0000537","EFO_0000712","MONDO_0001641","EFO_0000668","EFO_0005672","MONDO_0024664","EFO_0005251"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for cardiovascular disease and hypertension and has 10 investigational indications."}
{"id":"CHEMBL4297263","drugType":"Small molecule","blackBoxWarning":false,"name":"AROPLATIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aroplatin","L-nddp"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297264","canonicalSmiles":"C1=Cc2ccccc2NN=C1","inchiKey":"SVUOLADPCWQTTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZODIAZEPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzodiazepine"],"crossReferences":{"drugbank":["DB12537"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297276","canonicalSmiles":"CC1=Nc2ccc(Cl)cc2S(=O)(=O)[N-]1.C[N+](C)(C)CCO","inchiKey":"YLLWQNAEYILHLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAZOXIDE CHOLINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL181","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diazoxide choline"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297423","canonicalSmiles":"Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCN1CCN(C)CC1)c1nnc(C)n1-2","inchiKey":"PKQXLRYFPSZKDU-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RO-6870810","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-JQ35","BET INHIBITOR TEN-010","Bet inhibitor ro6870810","Jq-35, (s)-","RO6870810","Rg 6146","Ro-6870810","Ro6870810"],"crossReferences":{"drugbank":["DB15151"]},"linkedTargets":{"rows":["ENSG00000169925","ENSG00000204256","ENSG00000137948","ENSG00000141867"],"count":4},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","MONDO_0044889","EFO_0000222","EFO_0001378"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297709","drugType":"Unknown","blackBoxWarning":false,"name":"BMX-010","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEOL-10113","BMX-010","Bmx-010"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297867","drugType":"Protein","blackBoxWarning":false,"name":"EFMITERMANT ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACE-083","Ace-083","Efmitermant alfa"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297932","drugType":"Unknown","blackBoxWarning":false,"name":"DAS-181","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Das-181","Das181","Fludase","Oplunofusp"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4298009","drugType":"Antibody","blackBoxWarning":false,"name":"IERAMILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Humanised imp-701","Ieramilimab","LAG-525","LAG525","Lag 525","Lag525","NVP-LAG525"],"linkedTargets":{"rows":["ENSG00000089692"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0005537","EFO_0000756","MONDO_0007254"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4298196","drugType":"Small molecule","blackBoxWarning":false,"name":"VEVERIMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TRC-101","TRC101","Veverimer"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298198","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"VUPANORSEN SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AKCEA-ANGPTL3-LRx salt","ISIS 703802 salt","Vupanorsen sodium"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL437027","canonicalSmiles":"CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)C(C)C)C(N)=O","inchiKey":"QXZBMSIDSOZZHK-DOPDSADYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BOMBESIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bombesin","Bombesin 14"],"crossReferences":{"Wikipedia":["Bombesin"],"drugbank":["DB11724"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455946","canonicalSmiles":"NS(=O)(=O)c1ccc(NC(=O)c2n[nH]c3ccccc23)cc1","inchiKey":"MNHPHKFLWAPNOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL455946","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08133"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594350","canonicalSmiles":"C=C(F)C(=O)N1CCN(c2nc(OC[C@@H]3CCCN3C)nc3c2CCN(c2cccc4cccc(Cl)c24)C3)C[C@@H]1CC#N","inchiKey":"PEMUGDMSUDYLHU-ZEQRLZLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MRTX-849","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adagrasib","Kras g12c inhibitor mrtx849","MRTX-849","MRTX849","Mrtx-849","Mrtx849"],"linkedTargets":{"rows":["ENSG00000133703"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0009709","MONDO_0024880","EFO_0003060"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594466","drugType":"Unknown","blackBoxWarning":false,"name":"BIO89-100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIO89-100","Bio89-100","TEV-47948"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594522","drugType":"Unknown","blackBoxWarning":false,"name":"AMG-404","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 404","AMG-404","Amg 404","Amg-404","Zeluvalimab"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL462605","canonicalSmiles":"Clc1ccc(CCCOCCCN2CCCCC2)cc1","inchiKey":"NNACHAUCXXVJSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PITOLISANT","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Wakix","Wakix, europe"],"synonyms":["BF-2.649","BF-2649","BF2.649","Bf2.649","HBS-101","Pitolisant","Tiprolisant"],"crossReferences":{"DailyMed":["pitolisant%20hydrochloride"],"Wikipedia":["Pitolisant"],"drugbank":["DB11642"]},"childChemblIds":["CHEMBL4164059"],"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0003086","MONDO_0005090","EFO_0005246","EFO_0003890","Orphanet_739","MONDO_0005180","MONDO_0018044","MONDO_0016158","MONDO_0007079"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for hypersomnia and narcolepsy-cataplexy syndrome and has 8 investigational indications."}
{"id":"CHEMBL4650336","canonicalSmiles":"COc1ccc([C@H]2c3[nH]c4ccc(Cl)cc4c3CCN2C(=O)Oc2ccc(Cl)cc2)cc1","inchiKey":"SRSHBZRURUNOSM-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMVODODSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emvododstat","PTC299","Ptc-299","Ptc299"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4650342","canonicalSmiles":"CCCN1C[C@H](CSCC(=O)NCCCC[C@@H](NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(CCC)C2)C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC(=O)[C@H](CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](Cc3ccc(O)cc3)NC2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21","inchiKey":"WLBJBODHTIKYSL-JFPOTJHNSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"ONZIGOLIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIM-23A760","Dopastatin","Onzigolide","TBR-760","Tbr-760"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650396","drugType":"Unknown","blackBoxWarning":false,"name":"GPI-0100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GPI-0100","GPI0100","Gpi-0100"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650454","drugType":"Unknown","blackBoxWarning":false,"name":"ABDAVOMERAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abdavomeran","BNT-162B1","Bnt162b1"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650476","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"COFIRASERSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cofirasersen","ION-827359","IONIS-ENACRX","Ion-827359","Ionis-enacrx"],"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL48396","canonicalSmiles":"Nc1ccc(S(=O)(=O)c2ccc(NCC(=O)O)cc2)cc1","inchiKey":"FKKUMFTYSTZUJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEDIASULFONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acediasulphone","N-p-sulfanilylphenylglycine","NSC-158324"],"crossReferences":{"Wikipedia":["Acediasulfone"],"drugbank":["DB08926"]},"childChemblIds":["CHEMBL2105931"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL516357","canonicalSmiles":"Nc1ncnc2c1nc(NCc1ccc(Cl)c(Cl)c1)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"VBJKVZXRYLCYGQ-XNIJJKJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL516357","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07045"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539","canonicalSmiles":"CC(=O)O","inchiKey":"QTBSBXVTEAMEQO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetasol","Acetic acid","Aci-jel","Earcalm","Orlex","Vosol"],"synonyms":["Acetic","Acetic Acid","Acetic Acid, Glacial","Acetic acid","Acetic acid glacial","Acetic acid, diluted","Acetic acid, glacial","Acetic acid,glacial","Aceticum acidum","Acetopyrine","Acidum aceticum","Acidum aceticum glaciale","Acopyrine","Antipyrine acetylsalicylate","Distilled vinegar","E-260","E260","FEMA NO. 2006","Glacial acetic acid","INS NO.260","INS-260","NSC-111201","NSC-112209","NSC-115870","NSC-127175","NSC-132953","NSC-406306","Orthoacetic acid","Pyrosal","Vinegar","Vinegar acid"],"crossReferences":{"DailyMed":["acetic%20acid,%20glacial"],"PubChem":["144211770"],"Wikipedia":["Acetic_acid"],"drugbank":["DB03166"],"chEBI":["15366"]},"childChemblIds":["CHEMBL4297336"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for inflammation and has 3 investigational indications."}
{"id":"CHEMBL545437","canonicalSmiles":"CCOC(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2.Cl","inchiKey":"NQIZCDQCNYCVAS-RQBPZYBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMIBEGRON HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1193948","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amibegron hcl","Amibegron hydrochloride","SR-58611A","SR58611A","Sr-58611a"],"crossReferences":{"Wikipedia":["Amibegron"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL56475","canonicalSmiles":"Oc1ccc(I)cc1","inchiKey":"VSMDINRNYYEDRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Iodo-Phenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Iodo-Phenol","4-Iodophenol"],"crossReferences":{"PubChem":["251919907"],"drugbank":["DB03002"],"chEBI":["43521"]},"childChemblIds":["CHEMBL3343677"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL582887","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2OP(=O)(O)O)c(=O)n1","inchiKey":"YQUAKORMLHPSLZ-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL582887","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03765"],"chEBI":["28507"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL599872","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1","inchiKey":"HPAPGONEMPZXMM-ONAXAZCASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VANIPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-7009","Vaniprevir"],"crossReferences":{"Wikipedia":["Vaniprevir"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL6259","canonicalSmiles":"CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)CC1","inchiKey":"NOCJXYPHIIZEHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dicural","Difloxacin","Pulsaflox"],"crossReferences":{"PubChem":["29218066"],"Wikipedia":["Difloxacin"],"drugbank":["DB11511"],"chEBI":["4537"]},"childChemblIds":["CHEMBL542414"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6273","canonicalSmiles":"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1","inchiKey":"XBJBPGROQZJDOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLEROXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Megalone"],"synonyms":["AM-833","Fleroxacin","Megalocin","RO 23-6240/000","RO-236240","RO-236240000"],"crossReferences":{"PubChem":["144206106","170466056","26719809","50112812"],"Wikipedia":["Fleroxacin"],"drugbank":["DB04576"],"chEBI":["31810"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL651","canonicalSmiles":"CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"USSIQXCVUWKGNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHADONE","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amidone","Diaminon","Dl-methadone","Dolophin","Dolophine","Heptadon","Heptadone","IDS-NM-002","Metasedin","Methadone","Methadose","Phenadone","Phy","Physeptone","Symoron","Westadone"],"crossReferences":{"DailyMed":["methadone%20hydrochloride"],"Wikipedia":["Methadone"],"drugbank":["DB00333"],"chEBI":["6807"]},"childChemblIds":["CHEMBL1200825"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","MONDO_0000726","EFO_0004240","EFO_0002610","MONDO_0041052","HP_0012532","EFO_0000180","EFO_0010702","EFO_0003843","EFO_0000311","EFO_1001951","EFO_0004220","EFO_0003890","EFO_0000764","HP_0004308","EFO_0004273","EFO_0003884","HP_0003419","EFO_0005611","EFO_0003047","EFO_0003917","EFO_0005799","HP_0008419"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1947 and has 3 approved and 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL778","canonicalSmiles":"Cc1cccc([C@H](C)c2c[nH]cn2)c1C","inchiKey":"CUHVIMMYOGQXCV-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXMEDETOMIDINE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Precedex"],"synonyms":["Dexmedetomidine","MPV-1440","Medetomidine, (s)-"],"crossReferences":{"DailyMed":["dexmedetomidine%20hydrochloride"],"PubChem":["11114268"],"Wikipedia":["Dexmedetomidine"],"drugbank":["DB00633"],"chEBI":["4466"]},"childChemblIds":["CHEMBL2106195"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["GO_0035483","EFO_0005232","EFO_0003777","EFO_0011061","EFO_0009386","EFO_0007486","EFO_0002610","EFO_0000275","HP_0012735","MONDO_0002009","EFO_0011057","EFO_0004777","HP_0000175","EFO_1000800","EFO_0005773","EFO_0004698","HP_0100543","EFO_0003931","EFO_0003870","MONDO_0008903","MONDO_0021666","EFO_1000632","MONDO_0004976","EFO_0009620","EFO_0000400","EFO_0009686","HP_0000360","EFO_0003756","MONDO_0005149","HP_0002093","EFO_0001074","HP_0012532","EFO_0005578","EFO_0002687","HP_0001919","EFO_0005323","EFO_0003758","EFO_0009516","HP_0100806","EFO_0000546","MP_0001845","MP_0001914","HP_0002045","MONDO_0001208","MONDO_0100096","EFO_0003957","EFO_0004888","HP_0001336","Orphanet_1478","EFO_0000516","MONDO_0002258","EFO_0000668","EFO_0004337","EFO_0003086","HP_0000303","MONDO_0005090","EFO_0006834","EFO_0000278","EFO_1001905","EFO_1001454","EFO_0008507","MONDO_0007254","EFO_0009267","EFO_0008568","EFO_1002048","EFO_0002950","MONDO_0001056","EFO_0000474","EFO_0003959","EFO_0009514","HP_0030834","MONDO_0005180","MONDO_0005129","MONDO_0005299","EFO_0002460","EFO_0005279","EFO_0005230","EFO_0000239","EFO_0000616","HP_0001337","EFO_0005774","HP_0002140","HP_0001662","MONDO_0021204","EFO_0004329","EFO_0001645","EFO_0000677","EFO_0002623","HP_0011110","EFO_0005207","EFO_1001884","EFO_0003818","EFO_0001073","EFO_0003843","HP_0002315","EFO_0002615","EFO_0000311","HP_0000713","EFO_0000537","HP_0001082","EFO_0003890","EFO_0000713","EFO_0010282","EFO_0004273","MONDO_0004975","EFO_0005611","MONDO_0043510","EFO_0003918","EFO_0005411","EFO_0003833","MONDO_0005178","EFO_0004264","EFO_0008516","EFO_0004282"],"count":114},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 64 investigational indications."}
{"id":"CHEMBL880","canonicalSmiles":"CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O","inchiKey":"GGXKWVWZWMLJEH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAMCICLOVIR","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Famciclovir","Famvir"],"synonyms":["BRL-42810","Famciclovir","Famvir","NSC-758921"],"crossReferences":{"DailyMed":["famciclovir"],"PubChem":["170464774","174006796","26719883","26748972"],"Wikipedia":["Famciclovir"],"drugbank":["DB00426"],"chEBI":["4974"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 6 approved and 2 investigational indications."}
{"id":"CHEMBL92401","canonicalSmiles":"CC(C)NNC(=O)c1ccncc1","inchiKey":"NYMGNSNKLVNMIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRONIAZID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Marsilid"],"synonyms":["Iproniazid","Iproniazide"],"crossReferences":{"PubChem":["11111333","11111334","50111104","90341605"],"TG-GATEs":["62"],"Wikipedia":["Iproniazid"],"drugbank":["DB04818"],"chEBI":["5958"]},"childChemblIds":["CHEMBL1256361","CHEMBL1534878"],"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression."}
{"id":"CHEMBL977","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O","inchiKey":"VWQWXZAWFPZJDA-CGVGKPPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE HEMISUCCINATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydrocortisone Hemisuccinate","Hydrocortisone succinate","NSC-757049","NSC-7576"],"crossReferences":{"DailyMed":["hydrocortisone%20sodium%20succinate"],"PubChem":["56422426","855704"],"drugbank":["DB14545"],"chEBI":["31677"]},"childChemblIds":["CHEMBL3989663","CHEMBL1200495"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0006834","EFO_0000220","EFO_0000403","MONDO_0000870","HP_0004798","EFO_0000565","EFO_0000309","EFO_0003032","EFO_1001936","EFO_1001947","MONDO_0004979","EFO_0009552","MONDO_0020743","EFO_0005752"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 3 approved and 7 investigational indications."}
